Riskpilot← Back to searchSign inGet full accessMedicinsim AB
ABDissolvedOrg 5569351231Other software publishing · NACE 5829Est. 20130 employees
Revenue 2023
SEK 0
EBITDA margin
—
0% vs 2022
Equity ratio
98.5%
Financial strength
Net profit 2023
SEK 0
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -1K | +0% |
| Net profit | SEK 0 | — |
| Total assets | SEK 2M | +2% |
| Equity | SEK 1,9M | +0% |
| Employees | 0 | — |
Legal name
Medicinsim AB
Org number
5569351231
Legal form
Aktiebolag
NACE code
5829 · Other software publishing
Founded
20 juni 2013
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt skapa, supporta, äga, och licensiera ut mjukvara och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 1 000 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 503 | −4 | −1 | −1 | −1 |
| Depreciation & amort. | −10 | −0 | −0 | −0 | −0 |
| EBIT | 493 | −4 | −1 | −1 | −1 |
| Net financials | — | −1 | — | — | 30 |
| Profit before tax | 492 | −1 | 0 | 0 | 0 |
| Tax | −105 | −0 | −0 | −0 | −0 |
| Net profit | 387 | −1 | 0 | 0 | 0 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 2 159 | 2 742 | 1 948 | 1 948 | 1 978 |
| Equity | 1 949 | 1 948 | 1 948 | 1 948 | 1 948 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 210 | 794 | 0 | 0 | 29 |
| Total debt | 210 | 794 | — | — | 29 |
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
20192023
Equity ratio
98.5%
This company
38.2%
Market median
+158% vs market
20192023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20192023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20192023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20192023
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20192023
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-07-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
GH Chief Executive Officer | Chief Executive Officer | 2022 |
JD Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Surgical Science Sweden AB
Medicinsim AB Board members of Medicinsim AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gisli Hennermark | Chief Executive Officer | 0 companies |
| Johan Daniel Haglund | Chief Auditor | 0 companies |
| Jan Olof Roland Bengtsson | Chairman | 0 companies |
| Anna Sofia Ahlberg | Board of Directors | 0 companies |